To view this email as a web page, click here.

FDA Approves Pembrolizumab for Small-Cell Lung Cancer

The FDA approved pembrolizumab as a treatment option for patients with metastatic small-cell lung cancer.

A 37-Year-Old Woman With Vaginal Bleeding

A 37-year-old woman presents with vaginal bleeding. An endometrial biopsy is obtained. What is your diagnosis?

IN CASE YOU MISSED IT

Enasidenib: A Promising Option for IDH2-Mutated Acute Myeloid Leukemia?

The authors explored the evidence supporting the safety and side effect profile of enasidenib, FDA-approved in August 2017 for relapsed/refractory AML.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.